First Eagle Investment Management LLC raised its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 182.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 785,666 shares of the company's stock after buying an additional 507,826 shares during the quarter. First Eagle Investment Management LLC owned 0.21% of LifeStance Health Group worth $5,790,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its holdings in LifeStance Health Group by 26.8% in the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company's stock valued at $24,170,000 after buying an additional 729,794 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in LifeStance Health Group by 36.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company's stock valued at $7,731,000 after buying an additional 297,723 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of LifeStance Health Group by 65.7% during the 4th quarter. SG Americas Securities LLC now owns 90,355 shares of the company's stock valued at $666,000 after acquiring an additional 35,823 shares during the period. JPMorgan Chase & Co. lifted its position in shares of LifeStance Health Group by 13.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company's stock valued at $662,000 after acquiring an additional 10,894 shares during the period. Finally, Point72 Asset Management L.P. lifted its position in shares of LifeStance Health Group by 24.9% during the 3rd quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company's stock valued at $7,703,000 after acquiring an additional 219,329 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.
LifeStance Health Group Price Performance
Shares of LFST stock traded up $0.01 on Thursday, hitting $6.82. 1,724,606 shares of the company's stock were exchanged, compared to its average volume of 1,501,269. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $8.61. The stock has a market cap of $2.62 billion, a P/E ratio of -26.23 and a beta of 1.27. The company has a 50 day moving average of $7.75 and a 200 day moving average of $7.35.
Insider Buying and Selling
In related news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares in the company, valued at $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 6.60% of the stock is owned by corporate insiders.
Analyst Ratings Changes
A number of analysts have recently weighed in on LFST shares. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. The Goldman Sachs Group upgraded LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 target price for the company in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, LifeStance Health Group presently has an average rating of "Hold" and a consensus target price of $8.63.
Read Our Latest Report on LFST
LifeStance Health Group Profile
(
Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Further Reading

Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.